Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Alx Oncology Holdings  stock

Learn how to easily invest in Alx Oncology Holdings  stock.

Alx Oncology Holdings  is a biotechnology business based in the US. Alx Oncology Holdings  shares (ALXO) are listed on the NASDAQ and all prices are listed in US Dollars. Alx Oncology Holdings  employs 44 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Alx Oncology Holdings 

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ALXO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Alx Oncology Holdings  stock price (NASDAQ: ALXO)

Use our graph to track the performance of ALXO stocks over time.

Alx Oncology Holdings  shares at a glance

Information last updated 2022-06-24.
Latest market close$8.10
52-week range$5.82 - $81.19
50-day moving average $10.16
200-day moving average $28.77
Wall St. target price$43.25
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.32

Buy Alx Oncology Holdings  shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
$0
$0
N/A
Financial advice powered by relationships, not commissions.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Alx Oncology Holdings  stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Alx Oncology Holdings  price performance over time

Historical closes compared with the close of $8.1 from 2022-06-29

1 week (2022-06-23) 8.72%
1 month (2022-05-27) 0.62%
3 months (2022-03-26) N/A
6 months (2021-12-30) -63.06%
1 year (2021-06-30) -85.19%
2 years (2020-06-26) N/A
3 years (2019-06-26) N/A
5 years (2017-06-26) N/A

Alx Oncology Holdings  financials

Gross profit TTM $107,000
Return on assets TTM -14.77%
Return on equity TTM -24.62%
Profit margin 0%
Book value $8.45
Market capitalisation $303.1 million

TTM: trailing 12 months

Alx Oncology Holdings  share dividends

We're not expecting Alx Oncology Holdings  to pay a dividend over the next 12 months.

Alx Oncology Holdings  overview

ALX Oncology Holdings Inc. , a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell carcinoma, human epidermal growth factor receptor 2 (HER2) positive gastric/gastroesophageal junction carcinoma, HER2-expressing breast cancer, and other solid tumors. The company's pre-clinical products include ALTA-002, a SIRPa TRAAC that offers ways to engage the innate and adaptive immune response to cancer. ALX Oncology Holdings Inc. has a collaboration agreement with Merck for a Phase 2 trial evaluating ALX148 in combination with pembrolizumab with and without chemotherapy in patients with head and neck cancer; Zymeworks on a Phase 1 trial evaluating ALX148 with the HER2-targeting bispecific antibody zanidatamab in patients with HER2-expressing breast cancer and other solid tumors; and Tallac Therapeutics for the development, manufacturing and commercialization of a novel class of cancer immunotherapeutics. It also has a license agreement with Selexis SA and Crystal Bioscience, Inc.

Frequently asked questions

What percentage of Alx Oncology Holdings  is owned by insiders or institutions?
Currently 13.709% of Alx Oncology Holdings  shares are held by insiders and 88.051% by institutions.
How many people work for Alx Oncology Holdings ?
Latest data suggests 44 work at Alx Oncology Holdings .
When does the fiscal year end for Alx Oncology Holdings ?
Alx Oncology Holdings 's fiscal year ends in December.
Where is Alx Oncology Holdings  based?
Alx Oncology Holdings 's address is: 323 Allerton Avenue, South San Francisco, CA, United States, 94080
What is Alx Oncology Holdings 's ISIN number?
Alx Oncology Holdings 's international securities identification number is: US00166B1052

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site